MeSH D009059 - mouth diseases
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D009057:Stomatognathic diseases
0 Companies
0 Drugs
Success rate
D009059:Â
Mouth diseases
D001528:Behcet syndrome
D002054:Burning mouth syndrome
0 Companies
0 Drugs
Success rate
D002180:Oral candidiasis
D004368:Dry socket
0 Companies
0 Drugs
Success rate
D005150:Facial hemiatrophy
0 Companies
0 Drugs
Success rate
D005155:Facial nerve diseases
0 Companies
0 Drugs
Success rate
D005158:Facial paralysis
D006472:Oral hemorrhage
0 Companies
0 Drugs
Success rate
D007967:Oral leukoedema
0 Companies
0 Drugs
Success rate
D008047:Lip diseases
0 Companies
0 Drugs
Success rate
D008158:Ludwig's angina
0 Companies
0 Drugs
Success rate
D008556:Melkersson-rosenthal syndrome
0 Companies
0 Drugs
Success rate
D009056:Mouth abnormalities
0 Companies
0 Drugs
Success rate
D009062:Mouth neoplasms
0 Companies
0 Drugs
Success rate
D009066:Edentulous mouth
0 Companies
0 Drugs
Success rate
D009625:Noma
0 Companies
0 Drugs
Success rate
D009912:Oral manifestations
0 Companies
0 Drugs
Success rate
D009914:Oral submucous fibrosis
0 Companies
0 Drugs
Success rate
D010510:Periodontal diseases
D011900:Ranula
0 Companies
0 Drugs
Success rate
D012466:Salivary gland diseases
0 Companies
0 Drugs
Success rate
D013280:Stomatitis
D014060:Tongue diseases
0 Companies
0 Drugs
Success rate
D014393:Oral tuberculosis
0 Companies
0 Drugs
Success rate
D016155:Oral fistula
0 Companies
0 Drugs
Success rate
D017573:Focal epithelial hyperplasia
0 Companies
0 Drugs
Success rate
D017676:Oral lichen planus
0 Companies
0 Drugs
Success rate
D019226:Oral ulcer
D019569:Hemifacial spasm
0 Companies
0 Drugs
Success rate
D020330:Bell palsy
0 Companies
0 Drugs
Success rate
D051261:Orofacial granulomatosis
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Lidocaine, Prilocaine | Emla |  | 1992-12-30 |  |  |
| Lidocaine | Lidocaine |  | 2018-01-16 |  |  | |
| Padagis | Lidocaine, Prilocaine | Lidocaine Prilocaine |  | 2021-07-27 |  |  |
| Taro Pharmaceutical | Lidocaine | Lidocaine |  | 1982-01-01 |  |  |
| Lidocaine, Tetracaine | Pliaglis | 2031-01-14 | 2006-06-29 |  |  | |
| Glenmark Pharmaceuticals | Lidocaine | Lidocaine |  | 2016-09-09 |  |  |
| Mylan | Lidocaine | Lidocaine |  | 2010-09-27 |  |  |
| Roche | Ceftriaxone, Lidocaine | Rocephin |  | 1984-12-21 | $261.442 M | Y2021 |
| AstraZeneca | Lidocaine, Prilocaine | Emla |  | 1998-02-04 |  |  |
| Lidocaine | Xylocaine |  | 1982-01-01 |  |  | |
| Lidocaine, Epinephrine | Xylocaine W/ Epinephrine |  | 1982-01-01 |  |  | |
| Lidocaine | Xylocaine W/ Glucose |  | 1982-07-07 |  |  | |
| Novartis | Heparin, Lidocaine, Dihydroergotamine | Embolex |  | 1984-11-30 |  |  |
| Wyeth | Lidocaine | Lidocaine |  | 1982-01-01 |  |  |
| Merck Sharp & Dohme | Dexamethasone, Lidocaine | Decadron W/ Xylocaine |  | 1982-01-01 |  |  |
1
2
3
4
5
6
...
8
>
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
0%0/1
Phase 3
100%1/1
Approved: 1Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use